Company intelligence / Profile preview

BePharBel

Courcelles, Hainaut Province (Wallonia), Belgiumbepharbel.com ↗

Ownership: Private
Employees: ~85
Development stage: Commercial

Overview

BePharBel operates as a commercial-stage CDMO offering end-to-end development and EU-GMP manufacturing of more than forty finished pharmaceutical products across over ten galenic forms. The company has developed innovative technologies such as the MMCR controlled-release syrup platform but does not appear to have its own clinical pipeline of new chemical entities. Its portfolio includes both proprietary and partner-developed medicines sold mainly in Belgium and Luxembourg.

Therapeutic areas: OtherDermatologyOphthalmology
Modalities: Small moleculeAntibioticMedical device (as a product class)Controlled release formulation technologySyrup-based drug delivery systemSolid dosage forms (tablets, capsules)Injectable formulationsCreams and semi-solids
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

pramipexole

Pre-clinical

Indications: Parkinson's disease

Partnerships

Sambrinvest (investor/supporter)various pharma partners via CDMO contracts

Beyond the preview

Go deeper on BePharBel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BePharBel.

Explore the full profile